Topic: Treatment

Seminar
4 seminars
SeminarVision Science

Neuro-Optometric Rehabilitation - an introduction to the diagnosis and treatment of vision disorders secondary to neurological impairment

Marsha Benshir
May 27, 2025
SeminarNeuroscience

Development of Interictal Networks: Implications for Epilepsy Progression and Cognition

Jennifer Gelinas
Columbia University Medical Center, NY
Nov 2, 2022

Epilepsy is a common and disabling neurologic condition affecting adults and children that results from complex dysfunction of neural networks and is ineffectively treated with current therapies in up to one third of patients. This dysfunction can have especially severe consequences in pediatric age group, where neurodevelopment may be irreversibly affected. Furthermore, although seizures are the most obvious manifestation of epilepsy, the cognitive and psychiatric dysfunction that often coexists in patients with this disorder has the potential to be equally disabling.  Given these challenges, her research program aims to better understand how epileptic activity disrupts the proper development and function of neural networks, with the overall goal of identifying novel biomarkers and systems level treatments for epileptic disorders and their comorbidities, especially those affecting children.

SeminarMedicineRecording

Migraine Headache: the revolution and its evolution

Michael Moskowitz
Harvard Medical School, USA
Jul 29, 2021

This seminar will focus on the extraordinary shift in migraine research during the last 4 decades with the discovery of the trigeminovascular system (TVS) and it’s major impact on pathophysiology and treatment.  Compelling evidence supporting the importance of TVS, cortical spreading depression and parameningeal inflammation will be explored as will the implications of newly discovered microvascular channels within the meninges on an attack.

SeminarMedicineRecording

New Frontiers in Understanding and Treating Migraine Headaches

Lars Edvinsson
Lund University, Sweden & University of Copenhagen, Denmark
May 27, 2021

In this presentation I will describe how the CGRP project started and culminated in the development of gepants and mAbs for successful therapy. The outstanding question regarding the preponderance of female migraineurs also remains. I will present views on the reason behind this and suggest that understanding the hormonal influence will pave the way to alleviating hormone related migraine.

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.